Clinical trial

Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

NCT00155259

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-10-01

PhasePHASE2

Study timeline

Study start (unknown)2004-10-01Date precision: month

Registry last updated2007-07-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Docetaxel , Cisplatin , CapecitabineDRUG

Sponsors & collaborators

National Taiwan University Hospitallead sponsor

Mapped research locations

TaipeiTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00155259 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.